Atlas Trials

Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Conditions

Clinical trial NCT04921566 · COMPLETED

Trial details

NCT number
NCT04921566
Sponsor
Pharmtechnology LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2021-06-05
Primary completion
2021-06-20
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.